New York-Presbyterian - Weill Cornell Medical Center is a clinical research site located in New York, New York, United States 10065.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
New York-Presbyterian - Weill Cornell Medical Center has participated in 4 clinical trials with 1 currently active.
Therapeutic areas: Kidney Transplantation in Highly Sensitized Patients, Platinum-resistant Ovarian Cancer, Alcoholic Hepatitis.
Sponsors: Hansa Biopharma AB, Genmab, Durect.
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
New York-Presbyterian - Weill Cornell Medical Center has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New York-Presbyterian - Weill Cornell Medical Center has 4 clinical trials on record, with 1 currently active. Their work covers Kidney Transplantation in Highly Sensitized Patients, Platinum-resistant Ovarian Cancer, Alcoholic Hepatitis.
Yes — New York-Presbyterian - Weill Cornell Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.